论文部分内容阅读
目的探讨实时超声造影在肝癌超声引导介入治疗后局部疗效判断中的应用价值。方法对32例肝癌患者(39个病灶)在超声引导介入治疗后进行SonoVue实时超声造影和增强CT检查,以最终诊断为标准评价实时超声造影的准确性。结果39个病灶中实时超声造影检查显示14个病灶有残存活性,与增强CT检查结果相符,而常规彩超仅检出4例,敏感性和准确性明显低于实时超声造影。结论实时超声造影是一种评价肝癌超声介入治疗疗效的有效可靠方法。
Objective To investigate the value of real-time contrast echocardiography in judging the local curative effect of ultrasound-guided interventional therapy of liver cancer. Methods SonoVue real-time contrast-enhanced ultrasound and contrast-enhanced CT were performed in 32 patients with liver cancer (39 lesions) after ultrasound-guided interventional therapy. The accuracy of real-time CEUS was evaluated by final diagnosis. Results Real-time contrast-enhanced ultrasound (CEUS) in 39 lesions showed residual activity in 14 lesions, which was consistent with enhanced CT findings. Conventional color Doppler ultrasound only detected 4 cases, the sensitivity and accuracy were significantly lower than those of real-time contrast-enhanced ultrasound. Conclusion Real-time contrast-enhanced ultrasound is an effective and reliable method to evaluate the efficacy of interventional ultrasound in the treatment of liver cancer.